- Home
- CCCC vs TWN Comparison
CCCC vs TWN Comparison
Compare CCCC & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- TWN
- Stock Information
- Founded
- CCCC 2015
- TWN 1986
- Country
- CCCC United States
- TWN Hong Kong
- Employees
- CCCC N/A
- TWN N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- CCCC Health Care
- TWN Finance
- Exchange
- CCCC Nasdaq
- TWN Nasdaq
- Market Cap
- CCCC 405.6M
- TWN 313.8M
- IPO Year
- CCCC 2020
- TWN N/A
- Fundamental
- Price
- CCCC $6.25
- TWN $45.52
- Analyst Decision
- CCCC Buy
- TWN
- Analyst Count
- CCCC 6
- TWN 0
- Target Price
- CCCC $10.50
- TWN N/A
- AVG Volume (30 Days)
- CCCC 731.1K
- TWN 20.1K
- Earning Date
- CCCC 10-30-2024
- TWN 01-01-0001
- Dividend Yield
- CCCC N/A
- TWN 1.10%
- EPS Growth
- CCCC N/A
- TWN N/A
- EPS
- CCCC N/A
- TWN N/A
- Revenue
- CCCC $29,378,000.00
- TWN N/A
- Revenue This Year
- CCCC $39.70
- TWN N/A
- Revenue Next Year
- CCCC N/A
- TWN N/A
- P/E Ratio
- CCCC N/A
- TWN N/A
- Revenue Growth
- CCCC 83.26
- TWN N/A
- 52 Week Low
- CCCC $1.06
- TWN $25.22
- 52 Week High
- CCCC $11.88
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- CCCC 54.57
- TWN 61.65
- Support Level
- CCCC $6.26
- TWN $43.82
- Resistance Level
- CCCC $7.14
- TWN $45.52
- Average True Range (ATR)
- CCCC 0.37
- TWN 0.95
- MACD
- CCCC 0.12
- TWN 0.11
- Stochastic Oscillator
- CCCC 58.99
- TWN 93.73
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.